Business Case

Disease area factbook creation for a peri-launch Hem-Onc asset

Our client, a mid-sized biopharma company, was looking to commercialize their first oncology asset and sought to develop an internally-aligned view on the first cancer indication’s landscape (AML). LSC was able to conduct and synthesize primary and secondary research to craft a comprehensive factbook for consistent reference by the client organization as they went through their launch process. Ultimately, the client was able to launch and position the novel product in a competitive market and exceed forecasted expectations.